Biomarkers in oncology are used to diagnose and monitor tumor response to treatment, contributing to monitoring and detecting recurrence after treatment. However, biomarkers have a low sensitivity when used alone, so it is often used in combination with other screening therapies to ensure accuracy in cancer diagnosis.